Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase 1 Clinical Trial

Adenoviral vectors (Ads) have been evaluated in clinical trials for glioma. However, systemic immunity against the vectors can hamper therapeutic efficacy. We demonstrated that combined immunostimulation and cytotoxic gene therapy provides long-term survival in preclinical glioma models. Because hel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ghulam Muhammad, A.K.M., Xiong, Weidong, Puntel, Mariana, Farrokhi, Catherine, Kroeger, Kurt M., Salem, Alireza, Lacayo, Liliana, Pechnick, Robert N., Kelson, Kyle R., Palmer, Donna, Ng, Philip, Liu, Chunyan, Lowenstein, Pedro R., Castro, Maria G.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3545520/
https://ncbi.nlm.nih.gov/pubmed/22950971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hgtb.2012.060
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados